What are the treatment options for vulvar pruritus?
External genital itching, or pruritus vulvae, is a common symptom with numerous potential causes—including infections (such as vulvovaginal candidiasis, bacterial vaginosis, or trichomoniasis), dermatologic conditions (like lichen sclerosus, contact dermatitis, or psoriasis), hormonal changes (particularly during menopause leading to genitourinary syndrome of menopause), poor hygiene or over-cleansing, irritants (e.g., scented soaps, detergents, or synthetic underwear), and less commonly, neoplastic or systemic disorders. Accurate diagnosis requires a thorough history, physical examination—including careful inspection of the vulvar architecture, skin texture, color, and presence of excoriations or lesions—and targeted investigations such as vaginal pH testing, wet mount microscopy, fungal culture, or biopsy when indicated.
Treatment is strictly etiology-directed. For infectious causes, antifungal agents (e.g., topical clotrimazole or oral fluconazole for candidiasis), metronidazole or tinidazole (for bacterial vaginosis or trichomoniasis), or appropriate antimicrobials are prescribed. In cases of inflammatory dermatoses, low- to mid-potency topical corticosteroids (e.g., 0.05% clobetasol for lichen sclerosus, used intermittently under supervision) or calcineurin inhibitors (e.g., tacrolimus ointment) may be indicated. Hormonal insufficiency—especially estrogen deficiency in postmenopausal individuals—is effectively managed with localized estrogen therapy (e.g., vaginal estradiol tablets, creams, or rings) or newer non-hormonal options like ospemifene or dehydroepiandrosterone (DHEA) suppositories. Patient education on vulvar hygiene—using fragrance-free, hypoallergenic cleansers; avoiding douching and tight-fitting clothing; wearing cotton underwear; and applying emollients like plain petroleum jelly—is essential for both treatment and prevention of recurrence.
When symptoms persist despite empiric management or if atypical features are present (e.g., ulceration, induration, pigmented lesions, or failure to respond to standard therapy), prompt referral to a gynecologist or dermatologist for further evaluation—including colposcopy or biopsy—is critical to exclude malignancy or rare systemic conditions. A systematic, patient-centered approach ensures safe, effective, and sustainable relief.